Home/Axon Therapies/Chad Hoskins

CH

Chad Hoskins

President & Chief Executive Officer

Therapeutic Areas

Cardiovascular Disease Heart Failure

Axon Therapies Pipeline

Drug	Indication	Phase
SAVM Procedure	Heart Failure with Preserved Ejection Fraction (HFpEF)	Phase 2

Leadership Team at Axon Therapies

Howard Levin, MD

Board Member, CEO at Deerfield Catalyst

Independent Board Member

Board Member, Partner at Action Potential Venture Capital

View full Axon Therapies profile